SINGAPORE, April 21, 2016 /CNW/ - Zecotek Photonics Inc.
(TSX-V: ZMS; Frankfurt: W1I.F,
OTCPK: ZMSPF), a developer of leading-edge photonics
technologies for industrial, healthcare and scientific markets, is
pleased to announce that the Positron Emission Tomography (PET)
program at European Organization for Nuclear Physics (CERN) has
selected and ordered its patented LFS scintillation crystals for
its work on PET medical scanning devices. After a long process of
testing, Zecotek`s LFS scintillation crystals were chosen because
they provide the best results for coincidence timing resolution.
The LFS technology and formulation also present an intrinsic
capability and ability for the future development of even higher
performance LFS versions as compared to any competing crystals.
"Our tests show that Zecotek`s LFS scintillation crystals have a
faster coincidence time resolution for high resolution PET scanners
which improves the image quality and results in shorter scanning
times," said Dr. Crispin Williams, INFN physicist working at CERN.
"By using an LFS based array configuration we gain both performance
and cost effectiveness. We are very pleased with the results
obtained using Zecotek's LFS crystals, which we have selected for
our present work and continuing well into the future."
"We continue to enjoy the adoption trend of our patented LFS
crystals by the industry at large," said Dr. A.F. Zerrouk, Chairman, President, and CEO of
Zecotek Photonics Inc. "OEMs and researchers continue to be
impressed by the ability of our crystal and detector technologies
to reach even higher performance and cost effectiveness. Our unique
internationally patented off-stoichiometric formulations of
lutetium oxide with silicate, is such that no other crystal can
compete with its speed and brightness. Furthermore, our novel
technology allows for even higher performance versions which will
be made available to those OEMs using LFS, as new versions are
produced. We are proud to be working with CERN and associated
groups such as INFN on such an important project and look forward
to assisting them in the eventual commercialization program."
As previously announced on June 16,
2015, CERN researchers tested 15 mm lengths of LFS crystals
which showed an excellent CTR of 150 picoseconds (ps). CERN along
with other PET manufactures are moving toward PET scanners with
time-of-flight due to improved performance for patient imaging.
Time-of-flight PET devices produce quick, high resolution output,
but they require scintillation crystals which are very dense, with
high energy resolution and possess fast decay after absorbing gamma
photons emanating from the patient's body as a result of an
intravenous injection of radio trace substance. Zecotek`s LFS
crystal and all its versions, have high density, fast decay time,
good energy resolution, low afterglow and superior radiation
hardness. Radiation hardness is crucial for high energy physics and
homeland security.
About INFN
The National Institute for Nuclear Physics
(INFN) is the Italian research agency dedicated to the study of the
fundamental constituents of matter and the laws that govern them,
under the supervision of the Ministry of Education, Universities
and Research (MIUR). It conducts theoretical and experimental
research in the fields of subnuclear, nuclear and astroparticle
physics. All of the INFN's research activities are undertaken
within a framework of international competition, in close
collaboration with Italian universities on the basis of solid
academic partnerships spanning decades. Fundamental research in
these areas requires the use of cutting-edge technology and
instruments, developed by the INFN at its own laboratories and in
collaboration with industries. Groups from the Universities of
Rome, Padua, Turin, and Milan founded the INFN on
8thAugust 1951 to uphold
and develop the scientific tradition established during the 1930s
by Enrico Fermi and his school, with their theoretical and
experimental research in nuclear physics. In the latter half of the
1950s the INFN designed and built the first Italian accelerator,
the electron synchrotron developed in Frascati, where its first
national laboratory was set up. During the same period, the INFN
began to participate in research into the construction and use of
ever-more powerful accelerators being conducted by CERN, the
European Organisation for Nuclear Research, in Geneva. Today the INFN employs some 5,000
scientists whose work is recognised internationally not only for
their contribution to various European laboratories, but also to
numerous research centres worldwide.
About Zecotek
Zecotek Photonics Inc (TSX-V: ZMS;
Frankfurt: W1I) is a photonics technology company developing
high-performance scintillation crystals, photo detectors, positron
emission tomography scanning technologies, 3D auto-stereoscopic
displays, 3D metal printing, and lasers for applications in
medical, high-tech and industrial sectors. Founded in 2004,
Zecotek operates three divisions: Imaging Systems, Optronics
Systems and 3D Display Systems with labs located in Canada, Korea, Russia, Singapore and U.S.A. The management team is focused on
building shareholder value by commercializing over 50 patented and
patent pending novel photonic technologies directly and through
strategic alliances, the European Organization for Nuclear Research
(Switzerland), Beijing
Opto-Electronics Technology Co. Ltd. (China), NuCare Medical Systems (South Korea), the University of Washington (United States), and National NanoFab Center
(South Korea). For more
information visit www.zecotek.com and follow @zecotek on
Twitter.
This press release may contain forward-looking statements
that are based on management's expectations, estimates, projections
and assumptions. These statements are not guarantees of future
performance and involve certain risks and uncertainties, which are
difficult to predict. Therefore, actual future results and trends
may differ materially from what may have been stated.
Neither the TSX Venture Exchange nor its Regulation Service
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of the content of this news release. If you would like to
receive news from Zecotek in the future please visit the corporate
website at www.zecotek.com.
SOURCE Zecotek Photonics Inc.